Optomed Oyj
OMXH:OPTOMED
Net Margin
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
Peer Comparison
| Country | Company | Market Cap |
Net Margin |
||
|---|---|---|---|---|---|
| FI |
O
|
Optomed Oyj
OMXH:OPTOMED
|
57.1m EUR |
Loading...
|
|
| US |
|
Abbott Laboratories
NYSE:ABT
|
199.7B USD |
Loading...
|
|
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
176B USD |
Loading...
|
|
| US |
|
Stryker Corp
NYSE:SYK
|
146.5B USD |
Loading...
|
|
| IE |
|
Medtronic PLC
NYSE:MDT
|
126B USD |
Loading...
|
|
| US |
|
Boston Scientific Corp
NYSE:BSX
|
110.2B USD |
Loading...
|
|
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
47.6B EUR |
Loading...
|
|
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
53B USD |
Loading...
|
|
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
50.5B USD |
Loading...
|
|
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
47.3B USD |
Loading...
|
|
| US |
|
GE Healthcare Technologies Inc
NASDAQ:GEHC
|
38.5B USD |
Loading...
|
Market Distribution
| Min | -49 731.8% |
| 30th Percentile | -0.5% |
| Median | 2.3% |
| 70th Percentile | 7.2% |
| Max | 266.5% |
Other Profitability Ratios
Optomed Oyj
Glance View
Optomed Oyj engages in the provision of handheld fundus cameras and eye-screening solutions. The company is headquartered in Oulu, Oulun and currently employs 115 full-time employees. The company went IPO on 2019-12-09. The Group's Parent Company, Optomed Oyj, is responsible for, among other things, the management of the Group as well as finance and accounting functions, human resources, legal affairs and corporate communication. The Group's business is managed through two reportable segments: Devices and Software. The Devices segment develops, commercializes and manufactures easy-to-use and affordable handheld fundus cameras. The Software segment develops and sells screening software for diabetic retinopathy and cancer screening for healthcare organizations. The Optomed Group consists of the parent company Optomed Oyj and four subsidiaries in Finland, China, the USA and Hong Kong.
See Also
Net Margin is calculated by dividing the Net Income by the Revenue.
The current Net Margin for Optomed Oyj is -38.8%, which is below its 3-year median of -34.7%.
Over the last 3 years, Optomed Oyj’s Net Margin has decreased from -37.3% to -38.8%. During this period, it reached a low of -44% on Sep 30, 2024 and a high of -27.9% on Sep 30, 2023.
